intermittent fasting and glp-1 Added Value to Receptor Agonist: Lifestyle Modification to Improve Therapeutic Effects and Outcomes Intermittent fasting alone: 1-3% weight

(Shanghai) 2022;54(9):13141324

When combined with baseline biomarker data (serum B12, methylmalonic acid, homocysteine) and a personalized provider conversation, genetic context can support more informed decision-making about whether MIC B12 fits your metabolic profile and goals

While this medication absolutely has its place, Im increasingly concerned when I see people not just losing weight but also losing muscle mass

Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses